- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Recombinant Factor VIII (Kogenate FS, BAY14-2222)
Total 262 results
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, Hong Kong, Israel
-
Aljazeera HospitalCompleted
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, United Kingdom, Taiwan, Malaysia, Bulgaria, Hong Kong, Korea, Republic of, Netherlands, Turkey, Ukraine
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Poland, Germany, Taiwan, Israel, Ukraine, United Kingdom, Malaysia, Japan, Austria, Switzerland, Sweden, Bulgaria, Lithuania, Romania
-
Novo Nordisk A/SEnrolling by invitationCongenital Bleeding Disorder | Congenital FXIII DeficiencyJapan
-
OctapharmaCompletedSevere Hemophilia AGermany, Austria, United Kingdom, Bulgaria
-
Octagen CorporationBiomeasure Inc, Ipsen GroupCompletedHemophilia AUnited States
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumTerminatedHemophilia A | Hemophilia BUnited States
-
TakedaNot yet recruitingVon Willebrand Disease (VWD)
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedHemophilia ANetherlands, Spain, Italy, Turkey, Bulgaria, United States, Canada, Germany, Norway, Poland, Russian Federation, South Africa
-
Hospital Universitario La FeUnknownHemophilia A | Factor VIIISpain
-
BayerRecruitingHemophilia A | Prophylaxis of BleedingUnited States
-
United States Army Institute of Surgical ResearchCompleted
-
Baxalta now part of ShireCompleted
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Not yet recruiting
-
Baxalta now part of ShireCompletedHemophilia A | Congenital Factor VIII (FVIII) DeficiencyUnited Kingdom, France, Germany, Hungary
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, Australia, New Zealand
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Unknown
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHemophilia APoland, Belgium, France, Italy, Spain, United States, Australia, Netherlands, New Zealand, Sweden, Germany, Finland, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencySpain, United States, Canada, Italy, United Kingdom, Hungary
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyUnited Kingdom, Israel, United States
-
Baxalta now part of ShireCompletedHemophilia ABulgaria, Russian Federation
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
OctapharmaTerminated
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia AUnited States, France, Italy, Spain, Netherlands, United Kingdom, Ireland, New Zealand, Poland, Australia, Germany, Brazil, Sweden, Canada
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia AUnited States, United Kingdom, Spain, Hong Kong, Israel, New Zealand, Sweden, Australia, Brazil, Japan, Austria, Belgium, Italy, India, Switzerland, Canada, France, Germany, South Africa
-
Baxalta now part of ShireNo longer available
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, United Kingdom, Australia
-
AryoGen Pharmed Co.CompletedSevere Hemophilia AIran, Islamic Republic of
-
Nanjing Medical UniversityUnknown
-
BayerActive, not recruitingHemophilia ACanada, Spain, United States, Belgium, Italy, Taiwan, Slovenia
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia ASpain, United States, Australia, Singapore, Taiwan, Hong Kong, Malaysia, Bulgaria, United Kingdom, Switzerland, Ukraine, Turkey, Italy, Norway, France, Austria, Romania, Sweden, Poland, Germany, Hungary, Israel
-
Zhengzhou Gensciences IncJiangsu Gensciences lnc.Completed
-
Novo Nordisk A/STerminatedInflammation | Ulcerative ColitisPoland, Croatia, Denmark, Bulgaria, Hungary, Ukraine, Russian Federation
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States, Italy, United Kingdom, Germany, Austria, Netherlands, France
-
BayerRecruitingHemophilia A | Prophylaxis of Bleeding | Treatment of BleedingKorea, Republic of
-
BayerActive, not recruitingHemophilia ACanada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
-
BayerActive, not recruitingHemophilia A | Children | Prophylaxis of Bleeding | Treatment of BleedingCanada, United States, Brazil, Italy, Turkey, Argentina, Norway
-
Baxalta now part of ShireCompletedHemophilia A | Hemophilia BUnited States
-
TakedaCompleted
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States
-
Jiangsu Gensciences lnc.Completed
-
Jiangsu Gensciences lnc.Completed
-
St. James's Hospital, IrelandBaxter BioScienceUnknownSevere Haemophilia AIreland
-
Universiti Sains MalaysiaCompletedMassive Hemorrhage | Massive Blood Loss | Massive Blood Transfusion; ThrombocytopeniaMalaysia